drugset / Trial / NCT02468583
Proof of Concept Study Comparing FX006 to Kenalog®-40 in Patients With Post-Traumatic Osteoarthritis of the Knee
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study was a double-blind, randomized, parallel group, proof of concept study comparing FX006 to Kenalog®-40 (triamcinolone acetonide injectable suspension, USP) in patients with post-traumatic osteoarthritis of the knee.
Timeline
- Start
- 2015-02
- Primary completion
- 2016-07
- Completion
- 2016-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tafamidis | Unknown | 32 mg | Other |
| Comparator | Triamcinolone Acetonide | Other / unclassified | 40 mg | Other |